FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296996661> ?p ?o ?g. }

• W4296996661 abstract "As an emerging immune checkpoint molecule, indoleamine 2,3-dioxygenase 1 (IDO1) is an immunosuppressive rate-limiting enzyme in metabolism of tryptophan to kynurenine. The expression of IDO1 affected the prognosis of patients in cancers by regulating the kynurenine pathway, inhibiting the proliferation of T cells. However, the association between IDO1 and solid tumor prognosis was controversial. To further investigate the role of IDO1 expression in solid tumors, we conducted the systematic review and meta-analysis.We searched the Web of Science, PubMed, Embase, and Cochrane Library databases and China National Knowledge Infrastructure (CNKI) to identify studies evaluating the prognostic value of IDO1 in solid tumors. Overall survival (OS), progression-free survival (PFS), and disease-free survival (DFS) were extracted as the outcome. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated by using the fixed-effect/random-effect model, while heterogeneity, publication bias, and sensitivity between studies were also analyzed.Eighteen studies with 2,168 patients were included in this systematic review and meta-analysis. The results indicated that the high expression of IDO1 was associated with a shorter OS (n = 1926, HR = 1.60, 95% CI: 1.22-2.11, P = 0.001) and DFS (n = 327, HR = 2.65, 95% CI: 1.52-4.63, P = 0.001), while it was uncorrelated with PFS (n = 428, HR = 1.76, 95% CI: 0.99-3.14, P = 0.240). There was significant heterogeneity between studies on OS (I2 = 77.8%, P < 0.001). Subgroup analysis showed that age, gender, tumor type, follow-up period, and study quality were possible reasons for high heterogeneity. The result of the trim-and-fill method indicated that publication bias for OS had no impact on our results. Egger's test suggested no publication bias for PFS (P = 0.553) and DFS (P = 0.273). Furthermore, sensitivity analysis indicated the result was stable.High expression of IDO1 was associated with poor clinical outcomes, indicating that it could be a potential prognostic marker in various cancer types." @default.
• W4296996661 created "2022-09-25" @default.
• W4296996661 creator A5005011787 @default.
• W4296996661 creator A5012677271 @default.
• W4296996661 creator A5067414470 @default.
• W4296996661 date "2022-09-23" @default.
• W4296996661 modified "2023-09-26" @default.
• W4296996661 title "Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis" @default.
• W4296996661 cites W1569673965 @default.
• W4296996661 cites W1966064788 @default.
• W4296996661 cites W1967352051 @default.
• W4296996661 cites W1971907346 @default.
• W4296996661 cites W1984653919 @default.
• W4296996661 cites W1999601075 @default.
• W4296996661 cites W2003635644 @default.
• W4296996661 cites W2004528113 @default.
• W4296996661 cites W2006433415 @default.
• W4296996661 cites W2015260577 @default.
• W4296996661 cites W2082977560 @default.
• W4296996661 cites W2094644987 @default.
• W4296996661 cites W2108357035 @default.
• W4296996661 cites W2122814783 @default.
• W4296996661 cites W2127903252 @default.
• W4296996661 cites W2152061559 @default.
• W4296996661 cites W2179501428 @default.
• W4296996661 cites W2418878029 @default.
• W4296996661 cites W2554618897 @default.
• W4296996661 cites W2592502078 @default.
• W4296996661 cites W2619167255 @default.
• W4296996661 cites W2625838475 @default.
• W4296996661 cites W2759771344 @default.
• W4296996661 cites W2786095824 @default.
• W4296996661 cites W2789252410 @default.
• W4296996661 cites W2792241534 @default.
• W4296996661 cites W2793012277 @default.
• W4296996661 cites W2799403067 @default.
• W4296996661 cites W2888671848 @default.
• W4296996661 cites W2891033451 @default.
• W4296996661 cites W2891633089 @default.
• W4296996661 cites W2907307296 @default.
• W4296996661 cites W2911121545 @default.
• W4296996661 cites W2914702850 @default.
• W4296996661 cites W2921723025 @default.
• W4296996661 cites W2942663081 @default.
• W4296996661 cites W2969213651 @default.
• W4296996661 cites W2988692688 @default.
• W4296996661 cites W2995299616 @default.
• W4296996661 cites W3009505597 @default.
• W4296996661 cites W3019196465 @default.
• W4296996661 cites W3019611210 @default.
• W4296996661 cites W3022933332 @default.
• W4296996661 cites W3032380896 @default.
• W4296996661 cites W3032725565 @default.
• W4296996661 cites W3095690214 @default.
• W4296996661 cites W3101351446 @default.
• W4296996661 cites W3130280183 @default.
• W4296996661 cites W3154612073 @default.
• W4296996661 cites W3164178299 @default.
• W4296996661 cites W3169986140 @default.
• W4296996661 cites W3191751060 @default.
• W4296996661 cites W3208334490 @default.
• W4296996661 cites W4206956229 @default.
• W4296996661 cites W4220911574 @default.
• W4296996661 cites W4281249833 @default.
• W4296996661 cites W4282947433 @default.
• W4296996661 cites W4284884179 @default.
• W4296996661 cites W4285587152 @default.
• W4296996661 doi "https://doi.org/10.3389/fonc.2022.954495" @default.
• W4296996661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36212460" @default.
• W4296996661 hasPublicationYear "2022" @default.
• W4296996661 type Work @default.
• W4296996661 citedByCount "0" @default.
• W4296996661 crossrefType "journal-article" @default.
• W4296996661 hasAuthorship W4296996661A5005011787 @default.
• W4296996661 hasAuthorship W4296996661A5012677271 @default.
• W4296996661 hasAuthorship W4296996661A5067414470 @default.
• W4296996661 hasBestOaLocation W42969966611 @default.
• W4296996661 hasConcept C126322002 @default.
• W4296996661 hasConcept C143998085 @default.
• W4296996661 hasConcept C187960798 @default.
• W4296996661 hasConcept C207103383 @default.
• W4296996661 hasConcept C2776478404 @default.
• W4296996661 hasConcept C2776706248 @default.
• W4296996661 hasConcept C2777503454 @default.
• W4296996661 hasConcept C2780439572 @default.
• W4296996661 hasConcept C44249647 @default.
• W4296996661 hasConcept C515207424 @default.
• W4296996661 hasConcept C55493867 @default.
• W4296996661 hasConcept C71924100 @default.
• W4296996661 hasConcept C83478079 @default.
• W4296996661 hasConcept C86803240 @default.
• W4296996661 hasConcept C95190672 @default.
• W4296996661 hasConceptScore W4296996661C126322002 @default.
• W4296996661 hasConceptScore W4296996661C143998085 @default.
• W4296996661 hasConceptScore W4296996661C187960798 @default.
• W4296996661 hasConceptScore W4296996661C207103383 @default.
• W4296996661 hasConceptScore W4296996661C2776478404 @default.
• W4296996661 hasConceptScore W4296996661C2776706248 @default.
• W4296996661 hasConceptScore W4296996661C2777503454 @default.
• W4296996661 hasConceptScore W4296996661C2780439572 @default.

• next